SNX4 promotes glioblastoma progression through the TGFβ1/Smad signaling pathway and represents a potential therapeutic target.
- DOI
- 10.1186/s12967-026-08784-w
- Published
- 2026 Aug 11
- Container
- Journal of translational medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12967-026-08784-w,
title = {SNX4 promotes glioblastoma progression through the TGFβ1/Smad signaling pathway and represents a potential therapeutic target.},
author = {Yao Z and Xu P and Shen T and Hua Y and Ding S and Xu Y and Zhong W and Zhao X and Jiang S and Qi M and Jiang X and Ling S},
year = {2026},
journal = {Journal of translational medicine},
doi = {10.1186/s12967-026-08784-w},
url = {https://doi.org/10.1186/s12967-026-08784-w}
}RIS
TY - JOUR TI - SNX4 promotes glioblastoma progression through the TGFβ1/Smad signaling pathway and represents a potential therapeutic target. AU - Yao Z AU - Xu P AU - Shen T AU - Hua Y AU - Ding S AU - Xu Y AU - Zhong W AU - Zhao X AU - Jiang S AU - Qi M AU - Jiang X AU - Ling S PY - 2026 JO - Journal of translational medicine DO - 10.1186/s12967-026-08784-w UR - https://doi.org/10.1186/s12967-026-08784-w ER -
APA
Z, Y., P, X., T, S., Y, H., S, D., Y, X., W, Z., X, Z., S, J., M, Q., X, J., & S, L. (2026). SNX4 promotes glioblastoma progression through the TGFβ1/Smad signaling pathway and represents a potential therapeutic target.. Journal of translational medicine. https://doi.org/10.1186/s12967-026-08784-w
Source records
- pubmed · retrieved 2026-11-10T20:18:02.729Z